Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology

Fund Launch:
Dimension has launched its second fund, Dimension II, with $500 million to support entrepreneurs at the intersection of technology and life sciences15.

Investment Focus:
The fund focuses on investing in companies that combine technology and life sciences, including biotech, AI, machine learning, and lab automation1.

Portfolio Diversity:
Dimension's portfolio includes companies like Chai Discovery, Monte Rosa Therapeutics, and Kimia Therapeutics, which are pioneering in AI-driven drug discovery and therapeutic design1.

Investment Strategy:
Dimension emphasizes intentional and concentrated investing, preferring depth and rigor in underwriting and strong relationships with entrepreneurs5.

Global Reach:
The fund aims to partner with leading entrepreneurs globally, across all stages, to drive innovation at the interfaces of life science and technology5.

Research and Support:
Dimension has established a research function to provide critical intel and unbiased sounding boards for its portfolio companies and the broader ecosystem5.

Sources:

1. https://www.dimensioncap.com

5. https://www.dimensioncap.com/blog/announcing-dimension-ii